Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 3Completed 3Terminated 1

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 47Inflammatory Breast Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Ovarian Neoplasms 2Obesity 2Neoplasm Metastasis 2Central Nervous System Neoplasms 2Breast Carcinoma In Situ 2Breast Cancer Female 2Vitamin D Deficiency 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Sleep Wake Disorders 1Sexuality 1Recurrence 1Pulmonary Fibrosis 1Nutrition Disorders 1Neoplasms 1Melanoma 1Hormone-receptor-positive Breast Cancer 1Gliosarcoma 1Glioblastoma 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1ER+ Breast Cancer 1Carcinoma, Ovarian Epithelial 1Breast Diseases 1Breast Cancer Patients in Premenopausal 1Breast Cancer Organoids 1Astrocytoma 1

Interventions

Cyclophosphamide 9Epirubicin 6Docetaxel 6Fluorouracil 4Bevacizumab 4Trastuzumab 3Tamoxifen 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Neoadjuvant Therapy 3Thiotepa 2Paclitaxel 2Filgrastim 2Carboplatin 2pembrolizumab 1aldesleukin 1Vinorelbine 1Therapeutics 1Methotrexate 1Mesna 1Hypnosis 1High-Energy Shock Waves 1Goserelin 1Early Intervention, Educational 1Doxorubicin 1Cisplatin 1Chemotherapy, Adjuvant 1Capecitabine 1CMF regimen 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Inflammatory Breast Neoplasms × Tamoxifen × Clear all
NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
350 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
94 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡